Elevated aqueous ICAM-1 and reduced VEGF levels at baseline are associated with a favorable anatomic response to ranibizumab in DME, although there is not always direct correlation between anatomic and visual acuity response.
No takes yet. Share an insight, caveat, or question.
Hillier et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: